Johnson & Johnson Or Pfizer For Better Returns?

Johnson & Johnson's stock (NYSE: JNJ) has gained 27% since the March 23 lows, while Pfizer's stock (NYSE: PFE) is up 16%, both underperforming the broader S&P, which is up 39%. The lockdown in various parts of the world has had a negative impact on the pharmaceuticals industry worldwide...